The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is causing a global pandemic, and cases continue to rise. Most infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that could contribute to immunity. We performed a longitudinal assessment of individuals recovered from mild COVID-19 to determine whether they develop and sustain multifaceted SARS-CoV-2-specific immunological memory. Recovered individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months. Our data further reveal that SARS-CoV-2-specific IgG memory B cells increased over time. Additionally, SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral function: memory T cells secreted cytokines and expanded upon antigen re-encounter, whereas memory B cells expressed receptors capable of neutralizing virus when expressed as monoclonal antibodies. Therefore, mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks of antiviral immunity.
Pubmed ID: 33296701 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets Human IgA
View all literature mentionsThis unknown targets IgM
View all literature mentionsThis unknown targets Human IgG (H+L)
View all literature mentionsThis monoclonal targets GL7
View all literature mentionsThis monoclonal targets CD138
View all literature mentionsThis monoclonal targets CD45R (B220)
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-2
View all literature mentionsThis monoclonal targets IL-6
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets IL-21
View all literature mentionsThis monoclonal targets CD154 (CD40 Ligand)
View all literature mentionsThis monoclonal targets Human CD127
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets TCR gamma/delta
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-22
View all literature mentionsThis monoclonal targets IL-17A
View all literature mentionsThis monoclonal targets IL-13
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD194
View all literature mentionsThis monoclonal targets CD185 (CXCR5)
View all literature mentionsThis monoclonal targets CD127 (IL-7 Receptor α)
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets T-bet
View all literature mentionsThis monoclonal targets CD183 (CXCR3)
View all literature mentionsThis monoclonal targets Bcl-6
View all literature mentionsThis monoclonal targets CD278 (ICOS)
View all literature mentionsThis monoclonal targets FoxP3
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis monoclonal targets CD196 (CCR6)
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD185 (CXCR5)
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis monoclonal targets T-bet
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD307e (FcRL5)
View all literature mentionsThis monoclonal targets IgA
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets IgD
View all literature mentionsThis monoclonal targets IgM
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets Human CD20
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD41
View all literature mentionsThis monoclonal targets CD163
View all literature mentionsThis monoclonal targets CD9
View all literature mentionsThis monoclonal targets CD66b
View all literature mentionsThis monoclonal targets CD89
View all literature mentionsThis monoclonal targets CD123
View all literature mentionsThis monoclonal targets CD10
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets CD56 (NCAM-1)
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD15
View all literature mentionsThis monoclonal targets CD16 (FcγRIII)
View all literature mentions